Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernesto Vigna

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
European Journal of Haematology|October 29, 2025
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating AgentsErnesto Vigna, Antonella Bruzzese, Enrica Antonia Martino, et al.
European Journal of Haematology|March 6, 2025
Therapeutic Strategies for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal AntibodiesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|May 25, 2026
Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric AssessmentAntonella Bruzzese, Enrica Antonia Martino, Santino Caserta, et al.
Expert Opinion on Pharmacotherapy|September 24, 2013
An old drug with a new future: bendamustine in multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Investigational Drugs|October 4, 2017
Venetoclax for the treatment of chronic lymphocytic leukemiaMassimo Gentile, Annamaria Petrungaro, Giuseppina Uccello, et al.
Expert Opinion on Biological Therapy|September 11, 2024
Mosunetuzumab for the treatment of follicular lymphomaCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
Frontiers in Oncology|July 7, 2020
Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case ReportCirino Botta, Nadia Caruso, Sabrina Bossio, et al.
Expert Opinion on Pharmacotherapy|December 25, 2025
Reshaping multiple myeloma treatment: recent breakthroughsEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Expert Review of Hematology|June 25, 2025
Maintenance therapy after ASCT in newly diagnosed multiple myeloma patients: single agent <i>versus</i> combination drugsEnrica Antonia Martino, Ernesto Vigna, Caterina Labanca, et al.
Hematological Oncology|February 16, 2023
Myelodysplastic syndromes with ring sideroblastsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
European Journal of Haematology|October 29, 2025
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating AgentsErnesto Vigna, Antonella Bruzzese, Enrica Antonia Martino, et al.
European Journal of Haematology|March 6, 2025
Therapeutic Strategies for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal AntibodiesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|May 25, 2026
Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric AssessmentAntonella Bruzzese, Enrica Antonia Martino, Santino Caserta, et al.
Expert Opinion on Pharmacotherapy|September 24, 2013
An old drug with a new future: bendamustine in multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Investigational Drugs|October 4, 2017
Venetoclax for the treatment of chronic lymphocytic leukemiaMassimo Gentile, Annamaria Petrungaro, Giuseppina Uccello, et al.
Expert Opinion on Biological Therapy|September 11, 2024
Mosunetuzumab for the treatment of follicular lymphomaCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
Frontiers in Oncology|July 7, 2020
Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case ReportCirino Botta, Nadia Caruso, Sabrina Bossio, et al.
Expert Opinion on Pharmacotherapy|December 25, 2025
Reshaping multiple myeloma treatment: recent breakthroughsEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Expert Review of Hematology|June 25, 2025
Maintenance therapy after ASCT in newly diagnosed multiple myeloma patients: single agent <i>versus</i> combination drugsEnrica Antonia Martino, Ernesto Vigna, Caterina Labanca, et al.
Hematological Oncology|February 16, 2023
Myelodysplastic syndromes with ring sideroblastsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Pageof 12